Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Minoru Hasegawa(University of Fukui), Kiyoto Takehara, Manabu Fujimoto(Osaka Gakuin University), Kenta Kikuchi
PubMed
February 1, 1997
Cited by 312
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438